From: Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
Day
PfAMA1 Malaria Vaccine
Tetanus toxoid vaccine
N
GIA (95Â % CI)
0
20
56 (25–44)
59 (19–50)
84
19
68 (7–64)
18
62 (19–53)
365
43 (26–31)
17
49 (25–36)